✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Hemo Organic Ltd.

HEMORGANIC

Market Cap
₹7 Cr.
P/E
0.00

Hemo Organic Ltd.

  • Hemo Organic
  • Decipher Labs
  • Ganga Pharma

FAQs on Hemo Organic Ltd. Shareprice

Hemo Organic has given lower returns compared to its competitors.
Hemo Organic has grown at ~5.17% over the last 9yrs while peers have grown at a median rate of 7.02%

Hemo Organic is not expensive.
Latest PE of Hemo Organic is 0, while 3 year average PE is 15.29.
Also latest EV/EBITDA of Hemo Organic is 0.0 while 3yr average is 3.16.

View FAQ's On Business

Growth Table

  • Hemo Organic Ltd.
  • Decipher Labs
  • Ganga Pharma

Balance Sheet

  • Hemo Organic Ltd.
  • Decipher Labs
  • Ganga Pharma

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Hemo Organic Ltd.
  • Decipher Labs
  • Ganga Pharma

Cash Flow

  • Hemo Organic Ltd.
  • Decipher Labs
  • Ganga Pharma

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Hemo Organic Ltd.
  • Decipher Labs
  • Ganga Pharma

Quarterly Results

  • Hemo Organic Ltd.
  • Decipher Labs
  • Ganga Pharma

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Hemo Organic Ltd. Financials

Hemo Organic balance sheet is weak and might have solvency issues

Yes, The net debt of Hemo Organic is increasing.
Latest net debt of Hemo Organic is ₹2.73 Crs as of Mar-26.
This is greater than Mar-25 when it was ₹1.46 Crs.

The profit is oscillating.
The profit of Hemo Organic is -₹0.78 Crs for TTM, ₹0.16 Crs for Mar 2025 and -₹0.26 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Hemo Organic latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Inventory, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech